Rapid and ongoing surveillance of COVID-19 and seasonal influenza vaccination status and intent is being used to improve accuracy of estimates of vaccination among key priority groups.
Seasonal influenza causes substantial respiratory disease burden each year. Combined with the ongoing COVID-19 pandemic, we could overwhelm an already taxed health care system and cause severe social and economic disruption. This yearlong project (Dec 2020 – Dec 2021), with funding from the Centers for Disease Control and Prevention (CDC), utilizes existing omnibus panel surveys of the general adult U.S. population to rapidly assess knowledge, attitudes, beliefs, and behaviors related to influenza and COVID-19 vaccines. Questions added to the twice monthly NORC AmeriSpeak Omnibus survey panel are intended to provide rapid measures of vaccination status to compare with other administrative and survey estimates, as well as provide more deeper context and understanding into adults’ vaccination intent or hesitations, perceptions of safety, location of vaccination, and reasons or motivations for vaccinating or not vaccinating that can be incredibly valuable for developing strategies and health communication messaging to increase confidence in vaccines.
This project utilizes existing probability-based omnibus panel survey to collect data twice a month from a nationally representative sample of 1,000+ adults in the US. Leveraging bi-monthly surveys with AmeriSpeak enables allows the flexibility to field new questions every month in order to assess emerging issues (e.g. risk perceptions of the new COVDI-19 delta variant) as well as in-depth questions on vaccination knowledge, attitudes, beliefs, and behaviors.
Findings will be used to improve accuracy of estimates of vaccination during the 2020-21 season among key priority populations; and to inform strategies and communications for implementation of future COVID-19 and influenza vaccination campaigns.